No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY

Bibliographic Details
Main Authors:	Owen, K, Mughal, SA, Beatty, S, James, T, McCarthy, M
Format:	Conference item
Published:	2013

Similar Items

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
by: Mughal, SA, et al.
Published: (2014)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

Altered cortisol metabolism in individuals with HNF1A-MODY
by: Juszczak, A, et al.
Published: (2020)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
by: Mughal, SA, et al.
Published: (2013)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
by: McDonald, T, et al.
Published: (2012)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
by: McDonald, T, et al.
Published: (2011)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
by: Nowak, N, et al.
Published: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
by: Nowak, N, et al.
Published: (2013)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
by: Selwood, M, et al.
Published: (2008)

Lipid profile indices in young people with GCK-MODY and HNF1A-MODY
by: Alla K. Ovsyannikova, et al.
Published: (2022-01-01)

Variants influencing age at diagnosis of HNF1A-MODY
by: Agnieszka H. Ludwig-Słomczyńska, et al.
Published: (2022-09-01)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
by: Mughal, SA, et al.
Published: (2013)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
by: Mughal, SA, et al.
Published: (2013)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
by: Juszczak, A, et al.
Published: (2018)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
by: Nicole Oosterom, et al.
Published: (2022-01-01)

Circulating CD36 is reduced in HNF1A-MODY carriers.
by: Siobhan Bacon, et al.
Published: (2013-01-01)

Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
by: Maja Baretić, et al.
Published: (2023-06-01)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
by: Gabriela Irene Garcia Brandes, et al.
Published: (2022-05-01)

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
by: Servitja, J, et al.
Published: (2009)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
by: Gloyn, A, et al.
Published: (2011)

Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study
by: Angham Almutair, et al.
Published: (2024-03-01)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
by: Owen, K, et al.
Published: (2010)

Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center
by: Sara Amaral, et al.
Published: (2023-02-01)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018)

Who Is Afraid of CRP? Elevated Preoperative CRP Levels Might Attenuate the Increase in Inflammatory Parameters in Response to Lung Cancer Surgery
by: Moritz Mecki Meyer, et al.
Published: (2020-10-01)

Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels
by: Fan Ping, et al.
Published: (2022-10-01)

The impact of inflammation on Resistin, IL-6 and CRP in Acute Myocardial Infarction Patients.
by: Ammal E. Ibrahim, et al.
Published: (2011-07-01)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
by: Harries, L, et al.
Published: (2009)

Molecular characterization and re-interpretation of HNF1A variants identified in Indian MODY subjects towards precision medicine
by: Babu Kavitha, et al.
Published: (2023-06-01)

Early developmental perturbations in a human stem cell model of MODY5/HNF1B pancreatic hypoplasia
by: Teo, Adrian Kee Keong, et al.
Published: (2018)

GCK‐MODY、HNF1A‐MODY和2型糖尿病的基础辅助检查的见解:一项系统回顾和meta分析
by: Jing Liu, et al.
Published: (2023-06-01)

A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population.
by: Weedon, M, et al.
Published: (2005)

Comparison of prioritisation strategies for selecting subjects with apparent type 1 diabetes for MODY gene sequencing
by: Owen, K, et al.
Published: (2007)

Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene
by: Juan Zhang, et al.
Published: (2023-08-01)

A Comprehensive Analysis of Hungarian MODY Patients—Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in <i>HNF1A</i>, <i>HNF1B</i>, <i>HNF4A</i>, <i>ABCC8</i> and <i>INS</i> Genes
by: Zsolt Gaál, et al.
Published: (2021-07-01)

Role of low frequency variants in HNF1A exons 8-10 encoding hepatocyte nuclear factor-1 alpha isoform A to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2010)

HNF4A haploinsufficiency in MODY1 abrogates liver and pancreas differentiation from patient-derived induced pluripotent stem cells
by: Joanita Jasmen, et al.
Published: (2019)